A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants
Clinical trial NCT05051553 · COMPLETED
Trial details
- NCT number
- NCT05051553
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-21
- Primary completion
- 2021-12-23
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.